title: Concomitant examination of inflammation and angiogenesis in the pathogenesis of primary moderate pterygium in a well-designed case-control study.
abstract: Pterygium is a common ocular lesion whose exact etiology is a point of contention. Chronic inflammation and angiogenesis are two major proposed mechanisms of the disease in the current literature. The objective of this study is to examine these two mechanisms in a very well-designed setting. In a case-control study, 24 tissue specimens from the patients with primary moderate pterygium (cases) and 15 specimens excised from the nasal bulbar region in healthy counterparts (controls) were compared in terms of the count of mast cells (inflammation), as well as the status of Cd31/vascular Endothelial Growth Factor (VEGF) expression (angiogenesis) in Tabriz Nikookari and Sina Teaching Hospitals. The case (mean age: 58.08 +/- 10.03 years, 84% males) and control (Mean age: 62.33 +/- 9.19 years, 80% males) groups were age-and sex-matched (p = 0.19, 0.75, respectively). The mean mast cell count was significantly higher in the case group (27.72 +/- 15.19 versus 12.00 +/- 7.09 cells mm(-2), p = 0.001). The study of immunoreactivity revealed that the positive expression (moderate-severe) of CD31 was significantly more frequent in the case group (88 versus 26.7%; p<0.001; Odds ratio = 20, 95% confidence interval 3.85-100). There was also higher rate of VEGF-positive (moderate-severe) cells in the group with pterygium (88 versus 20%; p<0.001; Odds ratio= 33.3, 95% confidence interval 5.00-100). This study indicates that both inflammation and angiogenesis play pivotal role, in parallel, in pathogenesis of pterygium.
authors: Department of Pathology, Tabriz University of Medical Sciences, Sina Hospital, Tabriz, Iran.
authors: Shahla
authors: S
authors: Talghini
authors: Departmnent of Ophthalmology, Tabriz University of Medical Sciences, Nikookari Hospital, Tabriz, Iran.
authors: Abdollah
authors: A
authors: Shenasi
mesh_terms: D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D003228:Conjunctiva / Q000098:blood supply / Q000473:pathology; D003315:Cornea / Q000098:blood supply / Q000473:pathology; D005260:Female; D006801:Humans; D007249:Inflammation / Q000150:complications* / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008407:Mast Cells / Q000378:metabolism / Q000473:pathology; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000473:pathology; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000378:metabolism; D011625:Pterygium / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
chemical_list: D019408:Platelet Endothelial Cell Adhesion Molecule-1; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A